PRRS White Paper issued
Veterinary experts just released a White Paper on
PRRS, which voices the view that if future research proceeds along suggested
pathways, effective vaccine strategies could reach the market within the next 5
to 10 years.
Porcine Reproductive and Respiratory Syndrome - or PRRS - is the most significant disease problem
facing the swine industry worldwide. Yet, nearly 20 years after its discovery,
there has been little success in developing economical and effective control
strategies for this highly variable viral disease.
But, a White Paper just released, voices the view that if
future research proceeds along suggested pathways, effective vaccine strategies
could reach the market within the next 5 to 10 years.
The paper is the result of the consideration of 22 national
experts in PRRS, virology, immunology, and vaccinology.
discussed the state of current knowledge about PRRS vaccinations at the
invitation of the University Of Illinois College Of Veterinary
The group included clinical veterinarians, academic
researchers, and vaccine industry scientists. The resulting white paper
represents a significant advance in achieving scientific consensus on the
knowledge gaps that must be addressed.
Future key areas
The White Paper identifies key
areas for future research - include identifying the mechanisms by which the PRRS
virus causes disease - and the components of the virus that play a role in
inducing protective immunity.
In the United States alone, PRRS is
estimated to have an economic impact between 560 million and 762 million dollars
annually on pork producers.
To comment, login here
Or register to be able to comment.